Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
7.61
+0.10 (1.33%)
At close: May 29, 2026, 4:00 PM EDT
7.60
-0.01 (-0.13%)
After-hours: May 29, 2026, 7:57 PM EDT
Teladoc Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,514 | 2,530 | 2,570 | 2,602 | 2,407 | 2,033 | |
Revenue Growth (YoY) | -1.50% | -1.54% | -1.26% | 8.13% | 18.40% | 85.81% |
Cost of Revenue | 772.29 | 771.59 | 751.27 | 760.03 | 743.99 | 650.26 |
Gross Profit | 1,742 | 1,758 | 1,818 | 1,842 | 1,663 | 1,382 |
Selling, General & Admin | 1,255 | 1,280 | 1,346 | 1,367 | 1,301 | 1,105 |
Depreciation & Amortization Expenses | 368.5 | 364.08 | 373.55 | 337.07 | 256.03 | 204.24 |
Research & Development | 275.83 | 277.92 | 307.27 | 348.52 | 333.63 | 311.88 |
Other Operating Expenses | 46.92 | 99.56 | 812.1 | 38.05 | 13,426 | 26.64 |
Total Operating Expenses | 1,946 | 2,021 | 2,839 | 2,091 | 15,316 | 1,648 |
Operating Income | -204.11 | -262.96 | -1,021 | -248.55 | -13,653 | -265.63 |
Interest Income | 30.59 | 36.77 | 57.07 | 46.78 | 12.67 | 0.78 |
Interest Expense | -19.32 | -19.71 | -23.8 | -22.28 | -21.94 | -81.14 |
Other Non-Operating Income (Expense) | 7.74 | 10.37 | -6.04 | 4.45 | -0.86 | -38.66 |
Total Non-Operating Income (Expense) | 19.01 | 27.43 | 27.23 | 28.95 | -10.13 | -119.03 |
Pretax Income | -185.11 | -235.53 | -993.65 | -219.61 | -13,663 | -384.66 |
Provision for Income Taxes | -13.96 | -35.21 | 7.59 | 0.76 | -3.81 | 44.14 |
Net Income | -171.15 | -200.32 | -1,001 | -220.37 | -13,660 | -428.79 |
Net Income to Common | -171.15 | -200.32 | -1,001 | -220.37 | -13,660 | -428.79 |
Shares Outstanding (Basic) | 177 | 176 | 171 | 165 | 161 | 157 |
Shares Outstanding (Diluted) | 177 | 176 | 171 | 165 | 161 | 157 |
Shares Change (YoY) | 3.07% | 3.32% | 3.64% | 1.93% | 2.88% | 73.40% |
EPS (Basic) | -0.97 | -1.14 | -5.87 | -1.34 | -84.60 | -2.73 |
EPS (Diluted) | -0.97 | -1.14 | -5.87 | -1.34 | -84.60 | -2.73 |
Shares Outstanding | 180.43 | 178.32 | 173.41 | 166.66 | 162.84 | 160.47 |
Free Cash Flow | 280.13 | 285.46 | 282.89 | 338.56 | 172.81 | 185.46 |
Free Cash Flow Growth | -1.87% | 0.91% | -16.44% | 95.91% | -6.82% | - |
Free Cash Flow Per Share | 1.58 | 1.62 | 1.66 | 2.06 | 1.07 | 1.18 |
Gross Margin | 69.29% | 69.50% | 70.76% | 70.80% | 69.09% | 68.01% |
Operating Margin | -8.12% | -10.39% | -39.73% | -9.55% | -567.27% | -13.07% |
Profit Margin | -6.81% | -7.92% | -38.97% | -8.47% | -567.53% | -21.09% |
FCF Margin | 11.14% | 11.28% | 11.01% | 13.01% | 7.18% | 9.12% |
EBITDA | 176.33 | 113.48 | -638.04 | 100.17 | -13,385 | -46.11 |
EBITDA Margin | 7.01% | 4.49% | -24.83% | 3.85% | -556.14% | -2.27% |
EBIT | -204.11 | -262.96 | -1,021 | -248.55 | -13,653 | -265.63 |
EBIT Margin | -8.12% | -10.39% | -39.73% | -9.55% | -567.27% | -13.07% |
Effective Tax Rate | 7.54% | 14.95% | -0.76% | -0.35% | 0.03% | -11.47% |